Chen Yukai, Wang Chengchen, Bai Binglong, Ye Mao, Ma Junjie, Zhang Jingying, Li Zhiyu
Department of Thyroid Surgery, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Department of General Surgery, International Medical Center of Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Front Surg. 2022 Mar 10;9:860130. doi: 10.3389/fsurg.2022.860130. eCollection 2022.
The endoscopic thyroidectomy bilateral areola approach (ETBAA) improved cosmetic outcomes significantly and is now widely applied. The usage of drainage tubes is controversial in conventional open thyroidectomy (COT), but studies about drainage placement decisions during ETBAA are still limited. This study aimed to determine the feasibility of having no drainage tube applied during ETBAA on patients with papillary thyroid carcinoma.
The clinical data of patients undergoing ETBAA from July 2018 to May 2021 was retrospectively collected. The patients were divided into two groups based on drain placement: no-drain and drain. The two groups were matched at a ratio of 1:1. Fifty-five patients from each group were finally included. Postoperative complications and follow-up data were compared between the two groups.
No significant difference was observed between the two groups in the incidence of postoperative complications, including hemorrhage, surgical site infection, and subcutaneous seroma. Compared with the drain group, the operation time of the no-drain group was significantly shorter [(107.75 ± 24.59) min vs. (119.91 ± 34.05) min, < 0.05]. The total and postoperative hospital stay was significantly shorter in the no-drain group [(2.40 ± 0.71) days vs. (4.78 ± 1.33) days, < 0.001, (2.04 ± 0.19) days vs. (2.15 ± 0.36) days, < 0.05], and the costs of surgical consumables were also significantly lower [(6,820.83 ± 164.29) CNY vs. (7,494.13 ± 216.7) CNY, < 0.05]. The postoperative pain score of the no-drain group was significantly lower than the drain group [(1.58 ± 0.63) vs. (1.89 ± 0.76), < 0.05].
No drainage applied during ETBAA on papillary thyroid carcinoma is safe and feasible. This practice does not increase the risk of postoperative complications, but it does shorten the operation time and hospital stay, as well as reduce medical costs. Furthermore, it alleviates the suffering of patients.
内镜甲状腺切除术双侧乳晕入路(ETBAA)显著改善了美容效果,现已广泛应用。引流管在传统开放性甲状腺切除术(COT)中的使用存在争议,但关于ETBAA术中引流放置决策的研究仍然有限。本研究旨在确定在接受ETBAA的甲状腺乳头状癌患者中不放置引流管的可行性。
回顾性收集2018年7月至2021年5月接受ETBAA的患者的临床资料。根据是否放置引流管将患者分为两组:无引流组和引流组。两组按1:1的比例匹配。最终每组纳入55例患者。比较两组术后并发症及随访数据。
两组在术后并发症发生率方面无显著差异,包括出血、手术部位感染和皮下血清肿。与引流组相比,无引流组的手术时间显著缩短[(107.75±24.59)分钟 vs.(119.91±34.05)分钟,P<0.05]。无引流组的总住院时间和术后住院时间显著缩短[(2.40±0.71)天 vs.(4.78±1.33)天,P<0.001,(2.04±0.19)天 vs.(2.15±0.36)天,P<0.05],手术耗材费用也显著降低[(6820.83±164.29)元 vs.(7494.13±216.7)元,P<0.05]。无引流组的术后疼痛评分显著低于引流组[(1.58±0.63) vs.(1.89±0.76),P<0.05]。
在甲状腺乳头状癌的ETBAA术中不放置引流管是安全可行的。这种做法不会增加术后并发症的风险,但确实缩短了手术时间和住院时间,降低了医疗成本。此外,还减轻了患者的痛苦。